Status:
COMPLETED
Vitamin D in HIV-Infected Patients on HAART
Lead Sponsor:
University of California, Los Angeles
Conditions:
Vitamin D Deficiency
HIV
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This is a research study to look at vitamin D deficiency (low levels) in men and women with HIV. As part of your regular medical care, you will be screened for vitamin D deficiency. If your levels are...
Eligibility Criteria
Inclusion
- HIV-positive men and women age 18 and older.
- HIV-1 RNA documented to be \< 200 copies/mL on their current ART regimen, with supporting viral load documentation in the 24 weeks prior to study entry.
- Subjects must receive primary HIV care at the UCLA CARE center.
- Subjects must be undergoing screening for vitamin D deficiency by their primary care provider at the time of study entry, or have undergone vitamin D screening in the 90 days prior to consent without yet initiating vitamin D supplementation (for insufficient subjects).
- Ability and willingness of subject to provide informed consent
Exclusion
- Use of vitamin D supplementation (not including 400 IU daily, the amount in a standard multivitamin) at the time of screening.
- HIV-infected subjects not on ART.
- HIV-infected subjects not suppressed on their current ART regimen (HIV-1 RNA \> 200 copies/mL in the 6 months prior to screening).
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT01250899
Start Date
October 1 2010
End Date
June 1 2012
Last Update
November 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA CARE Center
Los Angeles, California, United States, 90035